Trending Topic

roflilumast foam
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.

Allergic Conditions

An Introduction to Allergic conditions

Supported by:
EU Partner
Mark CompleteCompleted
BookmarkBookmarked

This year, we are celebrating our inaugural touchDERMATOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform dermatology in the years to come. Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of dermatology. We had the pleasure of learning about their unique career journeys, motivations, and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in dermatology today, along with their hopes for the future of the field. Congratulations to all our touchDERMATOLOGY Future Leaders, and thank you for sharing your stories, insights and ambitions with us.

Mark CompleteCompleted
BookmarkBookmarked

With a career that bridges continents and disciplines, we are delighted to feature Dr Yi-Kui Xiang in our touchDERMATOLOGY Future Leaders 2025 initiative. Based in Berlin, Germany, Dr Xiang serves as a clinical scientist at both the Charité Institute of Allergology and the Fraunhofer Institute for Immunology and Allergology, but also maintains a clinical role at the Shanghai Skin Disease Hospital in China. His research interests span from urticaria, IgE-mediated autoimmunity and allergology to alopecia, pruritus, psychodermatology and patient-reported outcomes.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

We are delighted to announce that Professor Luis FC Ensina has joined the Expert Faculty of touchDERMATOLOGY. A distinguished allergologist, Professor Ensina is renowned for his expertise in urticaria, drug allergies and angioedema. His extensive contributions to clinical care, research ...

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Renowned for his work in urticaria, drug allergies and angioedema, Professor Luis FC Ensina is a distinguished allergologist. As a Professor of the Division of Allergy, Clinical Immunology and Rheumatology at the Federal University of São Paulo, Brazil and ...

52 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Prof. Dr Vito Sabato, Dr Sigurd Broesby-Olsen, Prof. Prithviraj Bose

Multidisciplinary experts discuss the diagnosis and management of patients with systemic mastocytosis.

Developed by Touch
Coverage from: Dermatology Congress News 2023

Atopic march is a concept where the natural progression of atopic dermatitis culminates in allergies including food allergies, conjunctivitis and respiratory allergies, atopic march presents differently amongst patients and the order of progression can vary substantially. touchDERMATOLOGY were delighted to speak with Prof. Carsten Flohr (Guy’s & St Thomas’ NHS Foundation Trust, London, UK) around the progression of atopic march, the associated comorbidities, impact of early detection and prevention strategies on patient outcomes. The presentation 'Early intervention to prevent atopic march?' (Presentation ID D2T02.2A) was presented at EADV 2023, Berlin, 11-14 October 2023 #EADVCongress. Questions Could you describe the progression of atopic march? (0:11) What comorbidities are associated with atopic march? (1:19) What impact is early detection of atopic dermatitis thought to have in the prevention of atopic march? (1:56) What therapies are thought to prevent the development of atopic comorbidities? (3:21) Disclosures: Carsten Flohr has nothing to disclose in relation to this video interview. Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones and Katey Gabrysch. Filmed in coverage of the EADV Annual Meeting. This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress.  Click here for more content on atopic dermatitis & for further EADV 2023 highlights visit here.

Close Popup